[PDF] Top 20 Relación entre la binocularidad y el rendimiento escolar
Has 10000 "Relación entre la binocularidad y el rendimiento escolar" found on our website. Below are the top 20 most common "Relación entre la binocularidad y el rendimiento escolar".
Epirubicin dose and sequential hormonal therapy-Mature results of the HMFEC randomised phase III trial in premenopausal patients with node positive early breast cancer.
... of results from this trial. Secondly, we allocated endocrine therapy to ER-negative patients, who nowadays would not be expected to benefit from such treatment, because of uncertainty around ... See full document
20
Prognostic and predictive value of TP53mutations in node positive breast cancer patients treated with anthracycline or anthracycline/taxane based adjuvant therapy: results from the BIG 02 98 phase III trial
... in early breast cancer have reported a predictive role for TP53 muta- ...a phase II Xeloda in Neoadjuvant (XeNa) trial assessing capecitabine and docetaxel, with trastuzumab if ... See full document
12
Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy : results from the BIG 02-98 phase III trial
... in early breast cancer have reported a predictive role for TP53 muta- ...a phase II Xeloda in Neoadjuvant (XeNa) trial assessing capecitabine and docetaxel, with trastuzumab if ... See full document
5
HYPO FRACTIONATION VERSUS CONVENTIONAL FRACTIONATION IN POST MASTECTOMY ADJUVANT RADIATION IN BREAST CANCER
... consecutive patients satisfying the inclusion and exclusion criteria were analyzed ...the patients traveling from distant ...the patients in the hypofractionated arm are right sided tumour ... See full document
9
Dose dense adjuvant chemotherapy for primary breast cancer
... Breast cancer remains a worldwide public health concern, despite the fact that mortality rates have been declining in the USA, Canada, and Europe [25] Advances in detection, diagnosis, and treatment of ... See full document
10
Alternative Multidisciplinary Management Options for Locally Advanced Non-Small Cell Lung Cancer During the COVID-19 Global Pandemic
... for patients and staff due to their aerosolized ...lymph node > 1 cm on short- axis diameter as positive and therefore should be targeted with radiation ...However, patients who are staged ... See full document
16
Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21 gene recurrence score assay eligible women under age 65
... on breast cancer ...endocrine therapy and breast imaging for recurrence or progression, received by this growing group of breast cancer survivors is affected by GEP test- ... See full document
12
Are there candidates for high-dose chemotherapy in ovarian carcinoma?
... all patients, HDC does not improve advanced ovarian cancer ...young patients (less than 50 years of ...young patients have a higher frequency of BRCA alterations than older women, they may ... See full document
10
Gastric cancer: current and evolving treatment landscape
... of patients with HER2-positive gastric or GEJ cancer from ...for patients with HER2-positive advanced gastric or GEJ ...gastric cancer patients with HER2 amplification ... See full document
15
Review Article Efficacy and safety of nanoparticle albumin-bound paclitaxel for treating metastatic breast cancer: a meta-analysis
... conflicting results about the efficacy and toxicity of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) for treating metastatic breast ...value. Results: The meta-analysis included six RCTs ... See full document
185
Early Results of Omitting Completion Axillary Lymph Node Dissection in Sentinel Lymph Node Metastasis Positive Breast Cancer Patients
... was positive for metastasis following the sur- gery, the patient was allowed to choose one of two treatment options: 1) performance of completion ALND, followed by performance of adjuvant therapy, or 2) ... See full document
118
Original Article Concurrent versus sequential chemotherapy with hypofractionated radiotherapy in patients with inoperable locally advanced non-small cell lung cancer
... Lung cancer is the leading cause of cancer- related death and accounts for ...the patients have non-small cell lung cancer (NS- CLC) and the prognosis is poor, with a 5-year overall survival ... See full document
214
Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial.
... 4,000 patients, 2,000 in each arm leading to 959 events would give the study 80% power (two-sided ...of patients who could be reconsented for longer follow-up, it was estimated that it could take until 2022 ... See full document
18
Actualities on diagnosis, targeting and treating bone metastases in breast cancer with radiotherapy and new drugs
... disease presentation. Other conditions in which biopsy can be mandatory are necessities of differential diagnosis. The differential diagnosis for bone metastases includes chondrosarcoma, primary malignant lymphoma of the ... See full document
24
<p>Pertuzumab in the treatment of HER2-positive breast cancer: an evidence-based review of its safety, efficacy, and place in therapy</p>
... (HER2)-positive breast cancer is a distinct subset of breast cancer that results from overexpression of HER2 ...adjuvant therapy and neoadjuvant therapy of HER2- ... See full document
7
Changes in radiotherapy fractionation-breast cancer.
... whole breast/chest well is a standard of care in an increasing number of countries, it carries implications for how a tumour bed boost doses should be ...HIGH trial (N=2,658) tests the hypothesis that ... See full document
13
Review Article Meta-analysis of capecitabine-based chemotherapy versus capecitabine-free chemotherapy in patients with metastatic breast cancer
... in patients with metastatic breast can- ...metastatic breast cancer were ...criteria. Results: Our study showed that capecitabine-based chemotherapy had a similar clinical response, ... See full document
217
Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
... Adjuvant therapy for early BC causes accelerated bone mineral density (BMD) loss, especially in premenopausal patients. Bone is maintained through a continuous remodel- ing process involving ... See full document
14
Progress in adjuvant chemotherapy for breast cancer: an overview
... static breast cancer in patients who had progressed after anthracycline-based combination chemotherapy or who relapsed less than 6 months after adjuvant therapy ...static breast ... See full document
188
Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long term results of a randomised trial
... START trial that tests the safety and effectiveness of schedules delivering fractions of greater than ...for early breast cancer. In this trial, tumour control is the primary endpoint, ... See full document
5
Related subjects